Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2209 ARTÍCULOS , VIENDO DEL 1486 AL 1500

Uncovering the Healing Power of Stem Cells: Harnessing Regenerative Therapies for Alzheimer's Disease

Mehrabadi S.

Curr Aging Sci. 2025;18(3):175-184. doi: 10.2174/0118746098334856250106055739.

Microglial Responses to Alzheimer's Disease Pathology: Insights From "Omics" Studies

Reid AN, Jayadev S, Prater KE.

Glia. 2025 Mar;73(3):519-538. doi: 10.1002/glia.24666. Epub 2025 Jan 6.

Monocyte-derived macrophages act as reinforcements when microglia fall short in Alzheimer's disease

Abellanas MA, Purnapatre M, Burgaletto C, Schwartz M.

Nat Neurosci. 2025 Mar;28(3):436-445. doi: 10.1038/s41593-024-01847-5. Epub 2025 Jan 6.

Senescent brain cell types in Alzheimer's disease: Pathological mechanisms and therapeutic opportunities

Hudson HR, Sun X, Orr ME.

Neurotherapeutics. 2025 Apr;22(3):e00519. doi: 10.1016/j.neurot.2024.e00519. Epub 2025 Jan 6.

Potential of Nanoparticle based Antimicrobial Drug Repurposing to Efficiently Target Alzheimer's: A Concise Update on Evidence-based Research and Challenges Ahead

Biswal B, Satapathy BS, Mishra A, Maharana L, Pattnaik S.

Curr Drug Discov Technol. 2025;22(3):e15701638329824. doi: 10.2174/0115701638329824241220055621.

The interaction between orexin, sleep deprivation and Alzheimer's disease: Unveiling an Emerging Connection

Kourosh-Arami M, Ramezani M, Komaki A.

J Physiol Sci. 2025 Mar;75(1):100004. doi: 10.1016/j.jphyss.2024.100004. Epub 2025 Jan 2.

Actin Cytoskeleton at the Synapse: An Alzheimer's Disease Perspective

P A H, Basavaraju N, Gupta A, Kommaddi RP.

Cytoskeleton (Hoboken). 2026 Jan;83(1):15-28. doi: 10.1002/cm.21993. Epub 2025 Jan 22.

Research Progress in the Molecular Mechanism of NLRP3 Inflammasome in Alzheimer's Disease and Regulation by Natural Plant Products

Zu R, Lu H, Liu W, Shao S, Zheng J, Ying X, Zhou Y, Li Z, Wang W, Li D, Peng Q, Ma H, Zhang Z, Sun Y.

Mol Neurobiol. 2025 Jun;62(6):7296-7312. doi: 10.1007/s12035-025-04715-w. Epub 2025 Jan 28.

Perivascular brain clearance as a therapeutic target in cerebral amyloid angiopathy and Alzheimer's disease

Bonnar O, Eyre B, van Veluw SJ.

Neurotherapeutics. 2025 Apr;22(3):e00535. doi: 10.1016/j.neurot.2025.e00535. Epub 2025 Jan 30.

Microglial polarization in Alzheimer's disease: Mechanisms, implications, and therapeutic opportunities

Yang X, Wang J, Jia X, Yang Y, Fang Y, Ying X, Li H, Zhang M, Wei J, Pan Y.

J Alzheimers Dis. 2025 Mar;104(1):3-13. doi: 10.1177/13872877241313223. Epub 2025 Feb 2.

Postbiotics as a therapeutic tool in Alzheimer's disease: Insights into molecular pathways and neuroprotective effects

Aran KR, Porel P, Hunjan G, Singh S, Gupta GD, Rohit.

Ageing Res Rev. 2025 Apr;106:102685. doi: 10.1016/j.arr.2025.102685. Epub 2025 Feb 6.

Astrocyte and oligodendrocyte pathology in Alzheimer's disease

Ziar R, Tesar PJ, Clayton BLL.

Neurotherapeutics. 2025 Apr;22(3):e00540. doi: 10.1016/j.neurot.2025.e00540. Epub 2025 Feb 11.

Alzheimer's Disease: Exploring Pathophysiological Hypotheses and the Role of Machine Learning in Drug Discovery

Dominguez-Gortaire J, Ruiz A, Porto-Pazos AB, Rodriguez-Yanez S, Cedron F.

Int J Mol Sci. 2025 Jan 24;26(3):1004. doi: 10.3390/ijms26031004.

Reinforcing Nrf2 Signaling: Help in the Alzheimer's Disease Context

la Torre A, Lo Vecchio F, Angelillis VS, Gravina C, D'Onofrio G, Greco A.

Int J Mol Sci. 2025 Jan 28;26(3):1130. doi: 10.3390/ijms26031130.

Microglial NLRP3 Inflammasomes in Alzheimer's Disease Pathogenesis: From Interaction with Autophagy/Mitophagy to Therapeutics

Ayyubova G, Madhu LN.

Mol Neurobiol. 2025 Jun;62(6):7124-7143. doi: 10.1007/s12035-025-04758-z. Epub 2025 Feb 14.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias